COVID-19-associated dermatologic manifestations: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}} {{AE}} | {{CMG}} {{AE}}{{Nuha}} | ||
==Historical Perspective== | ==Historical Perspective== | ||
==Classification== | |||
==Epidemiology and Demographics== | |||
Revision as of 13:01, 11 June 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Nuha Al-Howthi, MD[2]